The firm's goal for its SeekIt platform is to combine the accessibility of antibody and antigen testing and the accuracy of PCR for use in low-resource settings.

The technology can more effectively test for antibiotic susceptibility in heteroresistant bacterial populations than existing approaches.

Genco Lab was accused of billing Medicaid and Medicare programs for unnecessary screening and confirmatory tests for the use of prohibited drugs.

The US Food and Drug Administration granted clearances for PCR-based infectious disease tests from multiple entities as well as other in vitro diagnostic tests.

The new ruling reverses a jury verdict from four years ago that handed ArcherDx, which no longer exists, $4.7 million in damages.